XML 20 R4.htm IDEA: XBRL DOCUMENT v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Revenues:    
Research and development revenue $ 1,295,451 $ 758,420
Costs and expenses:    
Costs of research and development revenue 1,027,278 680,197
Provision for contract losses 0 220,715
Research and development 2,101,628 1,765,474
Research and development - related party 1,215,536 437,621
General and administrative 4,522,676 5,030,354
Foreign currency exchange loss (gain), net 20,778 (249,059)
Total costs and expenses 8,887,896 7,885,302
Loss from operations (7,592,445) (7,126,882)
Other income:    
Settlement of litigation, net 0 4,358,223
Interest income, net 894,532 566,146
Total other income 894,532 4,924,369
Loss before income taxes (6,697,913) (2,202,513)
Benefit from income taxes 1,006,157 66,694
Net loss $ (5,691,756) $ (2,135,819)
Basic and diluted net loss per common share (USD per share) $ (0.21) $ (0.07)
Basic and diluted weighted-average common shares outstanding (in shares) 27,673,300 28,917,961